期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 10, 期 3, 页码 1045-1063出版社
MDPI
DOI: 10.3390/ijms10031045
关键词
HIV; encephalitis; NeuroAIDS; inflammation; GSK3 beta; CDK5
资金
- NIH [MH076681, MH79881, MH45294, MH5974, MH58164, DA12065]
- California NeuroAIDS Tissue Network [U01 MH83506]
- NIMH [MH 62512]
- NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH045294, P30MH062512, R21MH076681, U01MH083506, R01MH079881] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012065] Funding Source: NIH RePORTER
The cognitive deficits in patients with HIV profoundly affect the quality of life of people living with this disease and have often been linked to the neuro-inflammatory condition known as HIV encephalitis (HIVE). With the advent of more effective anti-retroviral therapies, HIVE has shifted from a sub-acute to a chronic condition. The neurodegenerative process in patients with HIVE is characterized by synaptic and dendritic damage to pyramidal neurons, loss of calbindin-immunoreactive interneurons and myelin loss. The mechanisms leading to neurodegeneration in HIVE might involve a variety of pathways, and several lines of investigation have found that interference with signaling factors mediating neuroprotection might play an important role. These signaling pathways include, among others, the GSK3 beta, CDK5, ERK, Pyk2, p38 and JNK cascades. Of these, GSK3 beta has been a primary focus of many previous studies showing that in infected patients, HIV proteins and neurotoxins secreted by immune-activated cells in the brain abnormally activate this pathway, which is otherwise regulated by growth factors such as FGF. Interestingly, modulation of the GSK3 beta signaling pathway by FGF1 or GSK3 beta inhibitors (lithium, valproic acid) is protective against HIV neurotoxicity, and several pilot clinical trials have demonstrated cognitive improvements in HIV patients treated with GSK3 beta inhibitors. In addition to the GSK3 beta pathway, the CDK5 pathway has recently been implicated as a mediator of neurotoxicity in HIV, and HIV proteins might activate this pathway and subsequently disrupt the diverse processes that CDK5 regulates, including synapse formation and plasticity and neurogenesis. Taken together, the GSK3 beta and CDK5 signaling pathways are important regulators of neurotoxicity in HIV, and modulation of these factors might have therapeutic potential in the treatment of patients suffering from HIVE. In this context, the subsequent sections will focus on reviewing the involvement of the GSK3 beta and CDK5 pathways in neurodegeneration in HIV.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据